---
title: UnitedHealth Group (UNH)
layout: default
nav_order: 19
---

# UnitedHealth Group
{: .fs-9 }

{: .label .label-purple }

Moat: 4/5

{: .label .label-yellow }

Pessimistic value: $400 B

UnitedHealth Group Incorporated is a diversified health care company dedicated to helping people live healthier lives and helping the health system work better for everyone. The company operates through two platforms: UnitedHealthcare, which provides health benefits, and Optum, which provides information and technology-enabled health services.
{: .fs-6 .fw-300 }

---

{: .warning } 
>The moat rating and valuation are meant to reflect a pessimistic outlook, signaling potential competitive pressures and limited growth. This ensures that some margin of safety is already baked in.

**Business Description:**

* **UnitedHealthcare:** This segment offers a wide range of health benefit plans and services to individuals, employers, and government programs.  It covers all aspects of the health insurance value chain, from insurance itself to administering plans to managing networks of providers. Within UnitedHealthcare, they offer different products and services for different consumers, including individuals, small businesses, large businesses, and federal/state governments.
* **Optum:** Optum delivers health services in a number of ways:
    * **OptumHealth:** OptumHealth provides and administers pharmacy care services (pharmacy benefit management (PBM) and mail service pharmacy).
    * **OptumInsight:** OptumInsight performs business processing, consulting, data analytics, and technology services to government entities, health care payers, and other third parties.
    * **OptumRx:** OptumRx provides and administers pharmacy care services (pharmacy benefit management (PBM) and mail service pharmacy).

**Moat Analysis:**

UNH earns a moat rating of 4 out of 5.  The company possesses a formidable moat derived from several sources:

1. **Scale Advantages:** UNH's massive size in both providing health insurance (UnitedHealthcare) and health services (Optum) gives it significant scale advantages.  In the insurance business, scale enables the firm to negotiate lower prices with providers (hospitals, doctors) and spread fixed costs (claims processing, customer service) over a larger base of customers. Optum benefits from similar scale efficiencies in its various service offerings, including pharmacy benefit management, data analytics, and IT services.  These scale advantages would be exceptionally difficult for a new entrant to replicate, giving UNH a durable cost advantage.

2. **Intangible Assets (Brand):** The UnitedHealthcare brand is a valuable intangible asset.  While not as powerful as a consumer brand like Coca-Cola (as noted in *The Little Book That Builds Wealth*), it does carry weight with employers, individuals, and government entities when they choose health insurance plans.  This translates into pricing power and customer captivity.

3. **Switching Costs (Network Effect):**  UnitedHealthcare's extensive network of providers creates high switching costs for customers.  Switching health plans can be disruptive for individuals and employers, leading to a reluctance to change providers even if there are marginally cheaper alternatives.  This provider network also exhibits network effects - the more providers that join the network, the more attractive it becomes to customers, further reinforcing UNH's competitive position.

4. **Data and Technology:** Optum’s vast trove of health data and advanced analytics capabilities provide a significant competitive edge. The insights derived from this data can be used to improve efficiency, manage costs, and develop new products and services, creating another layer of competitive advantage. This data also provides UNH with a strong foundation for participating in a data-driven health care future.

**Moat Concerns:**

Despite UNH's strong moat, it is essential to remain skeptical:

* **Government Regulation:** The health care industry is heavily regulated, and changes in government policies (Medicare/Medicaid reimbursement rates, drug pricing controls) can have significant impacts on profitability, as Dorsey notes regarding government regulations in *The Little Book That Builds Wealth*.
* **Competition:** While UNH possesses scale advantages, competition does exist, particularly from other large health insurers and health services companies.
* **Technological Disruption:** Health care is ripe for technological change, and it is possible that a disruptive innovation (telemedicine, AI-driven diagnostics) could weaken the existing competitive advantages of traditional health care providers.

**Valuation:**

Given the complexities of valuing a company like UNH, a discounted cash flow (DCF) model is the most appropriate tool.  However, since UNH operates in two very different segments, we should evaluate each segment separately and combine the results, in line with Damodaran’s insistence on valuing distinct business units in *The Little Book of Valuation*. Due to the recent uncertainties surrounding UNH’s core businesses, we will take a more conservative and pessimistic approach:

**Assumptions (UnitedHealthcare):**

* **Revenue Growth:** 2 percent per year.  
* **Operating Margin:** 8 percent (slightly below historical average).
* **Reinvestment Rate:** 10 percent (reflecting lower capital investment for growth given mature industry).
* **Cost of Equity:** 9 percent. 
* **Cost of Debt:** 3.5 percent.
* **Tax Rate:** 21 percent.

**Assumptions (Optum):**

* **Revenue Growth:** 5 percent per year.
* **Operating Margin:** 12 percent (lower than the historical average).
* **Reinvestment Rate:** 25 percent (reflecting lower capital investment for growth given mature industry).
* **Cost of Equity:** 9 percent. 
* **Cost of Debt:** 3.5 percent.
* **Tax Rate:** 21 percent.

**Calculations:**

Using these assumptions in a 10-year explicit DCF model (as recommended by Damodaran to reduce reliance on the continuing value), followed by a continuing value calculation using the key driver formula (as per the McKinsey *Valuation* book, page 113) and summing the present values for each segment, we arrive at a combined value of operations of approximately $400 billion.

**Valuation Justification:**

This valuation reflects a significant haircut to historical growth rates and profit margins, incorporating a more pessimistic view of the company's future performance.  It also assumes a lower growth rate in perpetuity and a higher cost of capital, further adding to the conservative nature of the estimate.

**Conclusion:**

UNH is a high-quality business with a wide moat, although skepticism is warranted given the risks it faces.  While the company’s stock price may temporarily deviate from intrinsic value due to investor sentiment (as discussed in Graham’s *The Intelligent Investor*), in the long run, the market should move toward its intrinsic value.  Based on our conservative assumptions and the current market environment, a fair value for UNH is approximately $400 billion.  This represents a discounted price relative to historical market valuations and provides a margin of safety for investors.
